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A B S T R A C T   
The transcription factor Nrf2 is a stress-responsive master regulator of antioxidant, detoxification and proteo-
stasis genes. In astrocytes, Nrf2-dependent gene expression drives cell-autonomous cytoprotection and also non- 
cell-autonomous protection of nearby neurons, and can ameliorate pathology in several acute and chronic 
neurological disorders associated with oxidative stress. However, the value of astrocytic Nrf2 as a therapeutic 
target depends in part on whether Nrf2 activation by disease-associated oxidative stress occludes the effect of any 
Nrf2-activating drug. Nrf2 activation classically involves the inhibition of interactions between Nrf2’s Neh2 
domain and Keap1, which directs Nrf2 degradation. Keap1 inhibition is mediated by the modification of cysteine 
residues on Keap1, and can be triggered by electrophilic small molecules such as tBHQ. Here we show that 
astrocytic Nrf2 activation by oxidative stress involves Keap1-independent non-canonical signaling. Keap1 defi-
ciency elevates basal Nrf2 target gene expression in astrocytes and occludes the effects of tBHQ, oxidative stress 
still induced strong Nrf2-dependent gene expression in Keap1-deficient astrocytes. Moreover, while tBHQ pre-
vented protein degradation mediated via Nrf2’s Neh2 domain, oxidative stress did not, consistent with a Keap1- 
independent mechanism. Moreover the effects of oxidative stress and tBHQ on Nrf2 target gene expression are 
additive, not occlusive. Mechanistically, oxidative stress enhances the transactivation potential of Nrf2’s Neh5 
domain in a manner dependent on its Cys-191 residue. Thus, astrocytic Nrf2 activation by oxidative stress in-
volves Keap1-independent non-canonical signaling, meaning that further Nrf2 activation by Keap1-inhibiting 
drugs may be a viable therapeutic strategy.   
1. Introduction 
Animals have developed adaptive, protective defence programs 
mediated by de novo gene expression to protect against oxidative stress. 
Key among them are those genes operating under the control of anti-
oxidant response elements (AREs) within their cis-acting promoter re-
gions [1,2]. ARE’s are bound by the transcription factor Nrf2 (encoded 
by Nfe2l2) in a complex with small Maf proteins. The key point of reg-
ulatory control is the presence of Nrf2 in the nucleus, under regulation 
by Nrf2’s inhibitor Kelch-like ECH-associated protein 1 (Keap1) [3,4]. 
Under un-stressed conditions, steady state Nrf2 levels are very low, as 
Keap1 interacts with Nrf2 primarily via its Neh2 domain and targets it 
for ubiquitin mediated degradation [5]. However, a variety of stressors 
acting on Keap1’s redox-sensitive cysteine residues interfere with its 
inhibition of Nrf2, allowing it to accumulate, enter the nucleus, and 
drive ARE-mediated gene expression, which include antioxidant, 
detoxification and proteostasis genes. 
Nrf2 plays an important role in influencing the trajectory of 
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neurodegenerative and neurological disease. Nrf2 deficient mice exac-
erbate pathology in models of AD, PD, Huntington’s disease, vascular 
impairment/stroke and multiple sclerosis, while genetic or pharmaco-
logical activation of Nrf2 has shown beneficial effects in these models 
through its capacity to attenuate various pathological processes such as 
neuroinflammation, mitochondrial dysfunction and oxidative stress 
[6–8]. In the CNS, astrocytes are a key site for Nrf2 activation, evidenced 
by early reporter gene studies [9–11]. In contrast, the Nrf2 pathway has 
negligible activity in forebrain neurons due to epigenetic repression of 
the Nrf2 gene promoter in early development [12] and has abnormally 
high instability of what little protein is made [13]. Nevertheless, Nrf2 
activation in astrocytes, either via small molecular Keap1 inhibitors, or 
astrocyte-specific overexpression not only protects the astrocytes 
themselves, but also protects nearby neurons in vitro by a mechanism at 
least in part due to the production and release of the antioxidant 
glutathione [10,14,15]. This non-cell-autonomous neuroprotective ef-
fect is also observed in mice over-expressing Nrf2 subjected to models of 
ALS, PD, stroke and hypo-perfusion [6,8]. 
Although these experiments show the importance of astrocytic Nrf2 
for brain health and as a therapeutic target, they do not address how 
Nrf2 is activated by endogenous stresses, particularly mild oxidative 
stress, which activates Nrf2 dependent gene expression in astrocytes and 
likely a contributor to Nrf2 activation of endogenous Nrf2 in response to 
stresses such as inflammation and ischemia/reperfusion (in which it has 
a neuroprotective effect [16,17]). A key issue for the therapeutic tar-
geting of Nrf2 in astrocytes (e.g. via small molecules) in neuro-
logical/neurodegenerative diseases associated with oxidative stress is 
whether such stress has already activated Nrf2 via Keap1 inhibition, 
thus occluding the effect of any therapeutic intervention. Surprisingly, 
we found that activation of Nrf2-dependent gene expression in astro-
cytes by mild oxidative stress occurs via a non-canonical Keap1-inde-
pendent pathway in contrast to pharmacological Keap1 inhibitors, 
rendering such compounds effective even under conditions of oxidative 
stress. 
2. Results 
In mixed cultures of cortical neurons and astrocytes, non-toxic 
(≤100 μM, Fig. S1a) concentrations of H2O2 induce classical Nrf2 
target genes Srxn1 and Hmox1 and Slc7a11 in WT but not Nrf2− /− cul-
tures ([16], confirmed in Fig. S1b), showing that no Nrf2-independent 
pathway is active in controlling these genes in the context of H2O2 
treatment. Moreover, astrocytes are the only contributor to Nrf2 re-
sponses in mixed cultures, because Nrf2 expression is repressed in 
Fig. 1. Oxidative stress induces Nrf2 
target genes in astrocytes but not neu-
rons. A,B) Neuron-free astrocyte cul-
tures (A) and astrocyte-free neuronal 
cultures (B) were exposed to H2O2 for 
4h after which RNA was harvested and 
RNA-seq performed. Genes significantly 
up- (red) and down- (blue) -regulated 
>1.5 fold (DESeq2 Benjamini 
Hochberg-corrected p-value <0.05) are 
shown (n = 3). Insets show pictures of 
immunofluorescent staining using an 
astrocyte-specific antibody (GFAP) and 
a neuron-specific antibody cocktail 
(Neurochrom). Both antibodies were 
used on both cultures to confirm their 
purity. C) A comparison of the expres-
sion (FPKM, Fragments Per Kilobase of 
transcript per Million mapped reads) of 
seven known Nrf2 target genes in 
neuron-free astrocyte cultures vs. 
astrocyte-free neuronal cultures ±
H2O2. * Benjamini Hochberg-corrected 
p-value <0.05 (control vs. H2O2). D) 
Mouse astrocytes were co-cultured with 
rat neurons, and treated as in (A) and 
(B) ± H2O2 and subjected to RNA-seq. 
We sorted the mouse (astrocyte) reads 
using our Python tool Sargasso [20] and 
analyzed differentially expressed genes 
as in (A) and (B). Inset illustrates the 
mixed culture of astrocytes and neu-
rons. E) For genes shown in (C), the fold 
change in co-cultured astrocytes is 
shown. * Benjamini Hochberg-corrected 
p-value <0.05 Con vs. H2O2. (For 
interpretation of the references to 
colour in this figure legend, the reader 
is referred to the Web version of this 
article.)   
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neurons to the extent that they are unable to mediate Nrf2-dependent 
gene expression [12,16]. As such, neither the electrophilic Keap1 in-
hibitor tBHQ nor H2O2, can trigger induction of these Nrf2 target genes, 
in contrast to the robust response of neuron-free astrocyte cultures [12, 
16]. 
Genome-wide analysis of responses to non-toxic doses of H2O2 in 
mouse cortical astrocyte cultures (neuron-free) and astrocyte-free 
neuronal cultures revealed that H2O2 induced a number of known 
Nrf2 target genes >2-fold in astrocytes including Srxn1 and Hmox1 and 
Slc7a11 but also Txnrd1, Maff, Osgin1, and Gclm (Fig. 1a,c). We also 
performed a systematic analysis of induction of Nrf2 target genes, 
defined in a comprehensive study [18] as those whose promoters 
contain a ChIP-seq peak and are either downregulated in Nrf2-deficient 
MEFs (Nrf2+/+ vs. Nrf2− /− ) or up-regulated in Keap1-deficient MEFs 
(Keap1+/+ vs. Keap1− /− ). 41 Nrf2 target genes as defined by this criteria 
were induced >2-fold in astrocytes (Table S1), but none of the 41 were 
induced in neurons (Fig. 1b and c, Table S1). Given that astrocytes are 
the only contributor to Nrf2 responses in neuron/astrocyte mixed cul-
tures, we wanted to use this preparation for subsequent experiments, 
applying doses of H2O2 that were not toxic to either neurons or astro-
cytes in the culture. The rationale behind this is that astrocytes most 
resemble an in vivo morphology and transcriptome when co-cultured 
with neurons [19] and so are best studied in the presence of neurons, 
and also their expression levels are higher than in neurons both basally 
and even more so post- H2O2 treatment, so the astrocyte expression 
dominates. To further confirm that mouse astrocytes respond appro-
priately to H2O2 when in co-culture we cultured mouse neurons with rat 
astrocytes, and employed our Python tool Sargasso which enables 
species-specific sorting of bulk RNA-seq reads in silico [20], thus 
profiling the (mouse) astrocytic response in the co-culture (Fig. 1d). 
Indeed, all the H2O2-induced Nrf2 target genes in Fig. 1c are induced in 
astrocytes when in co-culture (Figs. 1e), and 34 out of the larger set of 41 
Nrf2 target genes induced, and 1 other Nrf2 target gene (Fgd) was 
induced >2-fold in the co-cultured astrocytes but not induced in the 
astrocyte mono-culture (Table S1), though none were induced in 
astrocyte-free neuronal cultures (Table S1). We therefore studied 
astrocytic Nrf2-dependent gene expression in the context of mixed 
neuron/astrocyte cultures, focusing on Srxn1, Hmox1 and Slc7a11, 
where the level of expression in astrocytes dominates a mixed culture of 
neurons and astrocytes. 
We hypothesized that H2O2 activates Nrf2-dependent gene expres-
sion in astrocytes via the canonical pathway of inhibition of Keap1- 
mediated Nrf2 degradation, and should therefore be occluded by 
Keap1 deficiency. Basal expression of Srxn1, and Slc7a11 were increased 
in Keap1− /− cultures (as expected), and Hmox1 was much more 
modestly affected (likely to due to a negative feedback of constitutive 
Nrf2 activating signal on the Hmox1 promoter). Strikingly, H2O2 further 
induced expression of Srxn1, and Slc7a11 and Hmox1 (Fig. 2a–c). In 
contrast, classical Nrf2 activator tBHQ induced Srxn1, Hmox1 and 
Slc7a11 in WT but not in Keap1− /− cultures (Fig. 2d), consistent with 
tBHQ’s mechanism of action as a Keap1 inhibitor [21–23]. Thus, in 
contrast to tBHQ, mild oxidative stress induces Nrf2-dependent gene 
expression in astrocytes via a Keap1-independent mechanism. We also 
confirmed that neuron-free astrocyte mono-cultures respond similarly to 
H2O2: Srxn1, and Slc7a11 and Hmox1 were all induced by H2O2 
(Fig. S2a), their basal expression was elevated in Keap1− /− cultures vs. 
WT (Fig. S2b), and this expression was further induced by H2O2 despite 
the absence of Keap1 (Fig. S2c). 
Since Keap1 interacts with Nrf2’s Neh2 domain, the Neh2 ‘degron’ 
confers instability on fusion proteins, and Neh2-luciferase was devel-
oped as a reporter of treatments that influence Neh2-dependent degra-
dation [24] (Fig. 3a). Astrocytes were transfected with a plasmid 
encoding Neh2-luciferase, or a luciferase control, and treated with either 
tBHQ or H2O2. TBHQ significantly increased the luciferase signal in 
Neh2-luciferase expressing astrocytes, however, H2O2 treatment had no 
effect (Fig. 3b). Thus, tBHQ but not H2O2, inhibits Neh2-dependent 
protein degradation, further evidence that H2O2 is inducing 
Nrf2-dependent gene expression via a Keap1/Neh2-independent mech-
anism, distinct from the canonical pathway activated by tBHQ. (As a 
control, we observed no effect on the non-Neh2 fused Luciferase control, 
Fig. 3c).A direct prediction of this is that the effect of tBHQ and H2O2 
should be additive, rather than occlude each other, and indeed this is the 
case: combined treatment produced a larger induction of Nrf2 target 
genes than treatment alone (Fig. 3d and e), consistent with their distinct 
Fig. 2. Mild oxidative stress induces Nrf2- 
regulated gene expression in Keap1− /− cul-
tures. A-C) Mixed astrocyte/neuronal cul-
tures of the indicated genotypes were treated 
with the indicated doses of H2O2 for 6h after 
which expression of Srxn1 (A), Slc7a11 (B) 
and Hmox1 (C) was assessed by qRT-PCR 
and normalized to Gapdh. Expression levels 
presented herein relative to WT-control. *P 
< 0.05 two-way ANOVA with Tukey’s post- 
hoc test, # effect of genotype on basal levels 
(two-way ANOVA with Sidak’s post-hoc test, 
#P < 0.05 (n = 5–6). D) Mixed astrocyte/ 
neuronal cultures of the indicated genotypes 
were treated with tBHQ for 6h after which 
gene expression was assessed as in A-C. *P <
0.05, (compared with WT-control), two-way 
ANOVA with Tukey’s post-hoc test, (n =
4–6).   
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mechanisms of action. 
An alternative, Keap1-independent mechanism of action by which 
H2O2 activates Nrf2-dependent gene expression could involve direct 
regulation of Nrf2’s transactivation potential, which is mediated by two 
domains at the N-terminus, Neh5 and Neh4 [25]. We employed fusion 
proteins of the Gal4 DNA binding domain (GBD) to full length Nrf2 
(GBD-Nrf2), amino-acids 1–156 (GBD-Neh2-4), and amino acids 
153–227 (GBD-Neh5). All fusion proteins enhanced expression of a 
Gal4-luciferase reporter, relative to expression of the Gal4 DBD alone 
(Fig. 4a), although Neh5 was particularly potent, particularly as it 
appeared to be expressed at lower levels than GBD-Neh2-4 (Figs. S4a 
and b). Of note, H2O2 application induced reporter expression mediated 
by GBD-Nrf2 and by GBD-Neh5, but not by GBD-Neh2-4 (Fig. 4a). 
Collectively, these observations are consistent with induction of Nrf2’s 
transactivation properties by acting on its Neh5 domain. 
Cysteine residues have a well-defined role in sensing and conveying 
changes in cellular redox status [26,27]. The human Nrf2 Neh5 domain 
is known to harbor a redox-sensitive cysteine residue [28] so we 
mutated the equivalent cysteine residue in the murine Nrf2 (Cys-191) to 
create GBD-Neh5C191A. This point mutation did not influence expression 
levels of the construct (Figs. S4a and b) but not only reduced the basal 
transactivation potential of the Neh5 domain, it also abolished its 
response to H2O2 (Fig. 4b), pointing to this residue as a target in the 
induction of Nrf2-dependent gene expression in astrocytes by mild 
oxidative stress. A similar loss of basal and H2O2-induced activity was 
observed in full length Nrf2C191A compared to WT Nrf2, assaying their 
ability to activate an ARE reporter based on the Srxn1 promoter [29] 
(Fig. 4c). Both Nrf2C191A and WT Nrf2 were expressed at the same level, 
and showed similar subcellular localisation (Figs. S4c and d). Thus 
cysteine-191 plays a role in the context of the basal and H2O2-induced 
activity of Nrf2 without any alteration in protein stability or location. 
3. Discussion 
In this study we presented a previously unrecognized mechanism for 
astrocytic Nrf2 activation by mild oxidative stress that is independent of 
the classical Keap1 antagonism pathway, involving direct regulation of 
Nrf2 via the Neh5 transactivation domain. While it was assumed that 
Keap1 inhibition was the dominant mechanism for Nrf2 induction by 
oxidative stress in astrocytes, this had never been investigated until 
now. Overall, our data demonstrate that non-lethal oxidative stress ac-
tivates astrocytic Nrf2 in no small part via a Keap1-independent manner, 
meaning that the effects of oxidative stress and classical electrophilic 
Nrf2 inducers can be additive. This is relevant from a translational point 
of view because it suggests that even in cells experiencing oxidative 
stress, that classical electrophilic Nrf2 inducers can have an Nrf2- 
boosting effect, rather than their effects being occluded by the pre- 
existing ROS generation. Interestingly, recent work has shown that 
low-level H2O2 production in astrocytes leads to reduced extracellular 
ROS by tonically activating Nrf2 [30] suggesting that the atypical 
mechanism of Nrf2 activation by H2O2 in astrocytes (this study) may 
serve a protective role in the brain. 
It is important to note, however, that this non-canonical activation of 
Nrf2 target genes remains very different from the situation in neurons, 
where many Nrf2 target genes are regulated by neuronal activity in a 
manner completely independent of Nrf2 [31–33], forming part of an 
activity-dependent neuroprotective transcriptional program [34,35]. 
However, some aspects of the Keap1-independent mechanism reported 
here require further investigation. For instance, it will be worthwhile to 
study the influence of Nrf2-C191A on the endogenous expression of 
Nrf2-target genes and on Nrf2 cellular distribution given that Neh5 also 
possesses a redox-sensitive nuclear export sequence [28]. Moreover, the 
Keap1-independency of human astrocytes (including iPSC-derived as-
trocytes), increasingly used to study Nrf2 activation and influence on 
neurotoxicity [15,36,37], should be confirmed. To conclude, oxidative 
stress is a complex event and its control of Nrf2 activity is expected to be 
intricate involving regulation at the cellular and molecular level. 
Although oxidative stress activates Nrf2 independent of cell type, the 
underlying mechanism could be cell type-specific and may be influenced 
by the intensity and the duration of the insult. 
4. Materials and methods 
4.1. Primary cortical cultures 
Cells were prepared from E17.5 wild-type, Nrf2− /− and Keap1− /−
mice embryos as previously described [12,38,39] from Nrf2− /− and 
Keap1− /− mice, originally developed by Prof. M. Yamamoto laboratory 
Fig. 3. Oxidative stress and tBHQ act on Nrf2 additively via different 
mechanisms. A-C) tBHQ but not H2O2 inhibits Neh2-mediated protein 
degradation. A) Schematic representation of the Neh2-luc reporter system. 
Astrocytes within mixed astrocyte/neuronal cultures were transfected with 
Neh2-luc (B) or control luciferase reporter plasmid (C) plus a pTK-renilla 
plasmid. The approach to target astrocyte transfection within mixed 
neuronal/astrocyte cultures was described previously [38,42,43] and verified 
for this study (Figs. S3a and b). Treatment with tBHQ or H2O2 for 8h was 
carried out 6 days post transfection (DIV08) before assessing luciferase reporter 
activity. Firefly luciferase expression was normalized to Renilla luciferase 
control. *P < 0.05, two-way ANOVA with Tukey’s post-hoc test, (n = 3–4), 
Con-Luc, luciferase control vector. D,E) Mixed astrocyte/neuronal cultures 
were treated with H2O2 and/or tBHQ as indicated for 6h, gene expression was 
assessed by qRT-PCR and normalized to Gapdh. *P < 0.05, one-way ANOVA 
with Sidak’s post-hoc test (n = 5–6). 
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(University of Tohoku) [3,40] were obtained from Prof. John. D. Hayes 
(University of Dundee). However, Nrf2− /− mice have been backcrossed 
over six generations onto C57BL/6 genetic background [41]. Offspring 
of Nrf2− /− mice was generated through breeding of Nrf2− /− females and 
males. Matching C57BL/6 WT animals were used to generate parallel 
wild-type cultures. Keap1 heterozygote males and females were mated 
to produce Keap1+/+ and Keap1− /− littermates which were used for 
comparison. 
4.2. Statistical analysis 
All results were obtained from at least three biological replicates 
(defined as independently performed experiments on material from 
cortical cultures derived from different animals) and within each 
experiment 2 or 3 technical replicates were included per condition. Data 
is presented as mean ± standard error of the mean. Statistical testing was 
carried out using Student’s t-test. For studies employing multiple testing 
one or two-way analysis of variance (ANOVA) was applied. 
4.3. Other methods 
See Supplemental Methods for details of induction of stress and 
assessment of cell viability, of plasmids and primers used, plus details of 
luciferase reporter assays, qPCR and RNA-seq. 
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